biosurfit press / news

Find out more about the latest news and updates of biosurfit.

biosurfit singled out
by TV news program “Falar Global”

biosurfit, was singled out by the TV News channel “SIC Noticias” in their program “Falar Global”. biosurfit was highlighted as one of a few examples of a Portuguese startup company in the healthcare business going global.

 

See the full video on the SIC website:
http://sicnoticias.sapo.pt/arquivo/2012-11-03-medicina-tecnologica-anti-crise

 

About biosurfit
biosurfit is a Venture Capital backed diagnostics company founded in 2006. The company invented and developed breakthrough technologies that enable fast, precise and affordable blood analysis, aiming for the key parameters that doctors really want. These proprietary technologies are combined in the spinit® instrument, using a user-friendly reader and disposable disk cartridges for specific clinical conditions. The spinit® instrument uses only one drop of blood to deliver precise results within 10-15 minutes. Initial disposable cartridges to be launched in 2013 include CRP, Blood Count and an Inflammation Panel. It is planned that future tests will include diabetes and cardiac multi-parameter panels.

 

For more information, please contact:

Daniel Neves, CMO of Biosurfit, tel: +351 217500228

biosurfit announces a third successful surveillance audit
for the in vitro medical device standard ISO13485:2012,
demonstrating its strong commitment to continuous improvement.

Maintaining ISO 13485 and ISO 9001 certification is an important milestone and distinguishing differentiator for biosurfit. It demonstrates to our customers, collaborators and business partners, that we are dedicated to quality at every level of the organization.

 

“Every member of the biosurfit team takes an active role in following and supporting our quality policies, allowing us to lead the way in addressing current and future requirements of the clinical diagnostics market” said CEO, João Garcia da Fonseca.

 

This certification is crucial to medical device companies to create a standardized quality system for the design and manufacture of medical devices that meet both customer and regulatory requirements. The review was performed by TÜV Rheinland according to ISO 13485:2003 requirements, and focused on biosurfit´s design, manufacturing of the spinit® reader and test specific disposable disk cartridges.

 

The one day visit by an independent auditor included a review of core and supporting quality management procedures, manufacturing and quality control processes as well as customer related processes. In addition to checking for compliance with the ISO standards, this surveillance audit was also an opportunity to expand the scope of the company´s certification to include installation and servicing activities not previously covered by the Quality Management System.

 

“The ISO 13485 certification makes us stronger as a company and builds the level of confidence our customers are expecting from our products We are committed to delivering only products manufactured with the highest level of traceability and quality control.” added biosurfit´s Quality System Manager, Claudia Ferreira.

 

About biosurfit
biosurfit develops innovative medical diagnostics solutions in order to improve physician performance, by providing real-time and accurate results for blood analysis. Its core product is spinit®, a user-friendly reader that combined with a disposable cartridge uses one small drop of blood to give precise results within 10-15 minutes for multi-parameter test panels.

 

About TÜV-Rheinland
TÜV Rheinland is a leading international service provision group with 500 locations in 61 countries on all continents. In its role as an independent, neutral third party, TÜV Rheinland tests, monitors, develops, promotes and certifies products, equipment, processes and management systems as well as services on the basis of statutory specifications and other relevant performance benchmarks and standards.

For more information, please contact:

Claudia Ferreira, Quality System Manager of biosurfit, tel: +351 217500228

biosurfit singled out
by the Vision Systems Design Magazine

biosurfit, was singled out by the Vision Systems Design magazine in regards to spinit® blood diagnostic system.

 

Using a combination of imaging cameras, proprietary software and CD-like test cartridges, the spinit® takes one small drop of blood, analyses it, and gives precise results within 10-15 minutes. The CD-like cartridge in the spinit® incorporates several detection zones that include a biological recognition layer (BRL) containing antibody fragments immobilized on a gold surface that acts as a selective trap for a specific blood biomarker.
Read the full article on the Vision Systems Design website.

 

About biosurfit
biosurfit is a Venture Capital backed diagnostics company founded in 2006. The company invented and developed breakthrough technologies that enable fast, precise and affordable blood analysis, aiming for the key parameters that doctors really want. These proprietary technologies are combined in the spinit® instrument, using a user-friendly reader and disposable disk cartridges for specific clinical conditions. The spinit® instrument uses only one drop of blood to deliver precise results within 10-15 minutes. Initial disposable cartridges to be launched in 2013 include CRP, Blood Count and an Inflammation Panel. It is planned that future tests will include diabetes and cardiac multi-parameter panels.

For more information, please contact:

Daniel Neves, CMO of biosurfit, tel: +351 217500228

biosurfit successfully completes the surveillance audit
by TÜV Rheinland within the scope
of ISO13485 and ISO9001 certification

biosurfit, an ISO 13485:2004 and ISO9001:2008 certified in vitro diagnostics company concluded its first surveillance audit with TÜV Rheinland, a leading and globally recognized quality management systems certification body guaranteeing the company´s continuous commitment to delivering safe and highest quality product.

 

The ISO 13485:2003 and ISO9001:2008 are internationally recognized Medical Device Quality Management System (QMS) standards, both developed by the International Organization for Standardization (ISO). To be certified to the 13485:2003 standard, companies must implement a Medical Device QMS ensuring steps have been taken to identify, manage and minimize risks involved with the manufacturing and sales of medical devices. The 9001:2000 standard complements the 13485:2003 standard and requires a well-documented QMS that ensures consistency and improvement of working practices, including the products and services produced.

 

During one and a half days, an independent auditor reviewed quality management procedures, system operations and manufacturing processes at the company headquarters and at the manufacturing site (Marinha Grande, Portugal) to ensure compliance with both ISO standards and the European IVD directive 98/79/EC. The positive outcome of the surveillance audit underscored the company´s commitment to excellence at every stage of medical device design, development and manufacturing.

 

“The successful completion of this audit was the culmination of a series of activities conducted internally by the entire biosurfit team to ensure continued conformance to ISO requirements at all levels of the company. We are very proud of the outcome of this audit and feel this is a great opportunity to renew our company´s cultural commitment to the excellence and quality of our products” said Business Development and Quality Manager, Claudia Ferreira.

 

The Chief Operating Officer at biosurfit, Nuno Reis, PhD further emphasized the importance of the Quality Management System by referring to its constant development in order to meet the company´s needs “The outcome of the 2011 surveillance audit consolidates our belief in a Quality Management System that evolves everyday as the company grows and builds confidence in the team to face the challenges ahead”.

 

About biosurfit
biosurfit develops innovative medical diagnostics solutions in order to improve physician performance, by providing real-time and accurate results for blood analysis. Its core product is spinit®, a user-friendly reader that combined with a disposable cartridge uses one small drop of blood to give precise results within 15 minutes for multi-parameter test panels.

 

About TÜV-Rheinland
TÜV Rheinland is a leading international service provision group with 500 locations in 61 countries on all continents. In its role as an independent, neutral third party, TÜV Rheinland tests, monitors, develops, promotes and certifies products, equipment, processes and management systems as well as services on the basis of statutory specifications and other relevant performance benchmarks and standards.

biosurfit wins the “Growth Companies Competition”
in the HiT Barcelona – World Innovation Summit

biosurfit presented the spinit® platform, a user-friendly machine that combined with a disposable cartridge, uses just one small drop of blood to perform multi-parameter test panels in less than 15 minutes. spinit® will soon have the potential to perform a vast majority of blood tests combining cell and immuno-based diagnostics, with integrated sample preparation into the disposable cartridge. biosurfit will continuously develop different cartridge tests for the spinit® platform, addressing the physician’s needs.

 

“It is out great honor to receive such an award by a distinguished forum and wee are delihted to have participated in a contest that recognizes innovation and entrepreneurship in the world. The Global Entrepeneurship Competition, the HiT and the symposiums creates a fabulous integrated activity where global thought leaders, major corporations and investors from such different communities of the Silicon Valley, Boston and Barcelona can meet together with entrepeneurs from around the world and create together true value for society and their shareholders. The future of the innovation and entrepeneurship is being shaped by these types of initiatives and I congratulate the organization for its innovative approach and the impact it is generating in the entrepreneurial community” said Daniel Neves, CMO of biosurfit.

 

About biosurfit
biosurfit develops innovative medical diagnostics solutions in order to improve the performance and outcomes of physicians, by providing real- time and accurate results of blood analysis. It’s core product is spinit®, a user-friendly reader that combined with a disposable cartridge uses one small drop of blood to give precise results within 15 min for multi-parameter test panels.

 

About HiT Barcelona 2011
HiT Barcelona 2011 is an international summit that brings together corporate executives, entrepreneurs and investors from around the world on June 15th and 16th, 2011. Together they will size up the latest international trends in innovation and technology, identify new commercial innovations, network with the international innovation community and formalize new business and investments.

 

About Growth Company Competition
Growth Company Showcase is intended to bring together the leading young growth companies from around the world. The pupose is to create community and opportunities for these ventures that have progressed beyond the start-up phase. Easch member of the Nominating committee shall select one High potential growth company for each of following sectors: IT/Media, Healthcare, Cleantech. Judges will make their selections based on interviews and evaluation of the opportunities conducted at the events trade Show /marketplace and review of the company online one-minute elevator pitch and executive summary.

 

http://www.hitbarcelona.com/en/Investors.axd